Brief: Atara Biotherapeutics Presents Positive Preclinical Data On ATA3431

Atara Biotherapeutics

11/12/2023 17:54

Dec 11 (Reuters) - Atara Biotherapeutics Inc  ATRA.O :
    * ATARA BIOTHERAPEUTICS PRESENTS POSITIVE PRECLINICAL DATA
ON
ATA3431, A NEXT-GENERATION ALLOGENEIC CD20/CD19-TARGETED CAR, AT
THE 65TH ASH ANNUAL MEETING
    * ATARA BIOTHERAPEUTICS INC - NO OBSERVED TREATMENT-RELATED
TOXICITIES OR ALLOREACTIVITY
    * ATARA BIOTHERAPEUTICS INC - DATA SUPPORTS ADVANCEMENT INTO
IND-ENABLING STUDIES
    * ATARA BIOTHERAPEUTICS INC - EXCITED THAT ATA3431 IS
PROGRESSING
TOWARDS AN IND SUBMISSION IN 2025


 ((Reuters.Briefs@thomsonreuters.com;))